Sudden unexpected death in epilepsy (SUDEP) is a leading cause of premature death, affecting 1·00–1·14 per 1000 people with epilepsy annually.1 Identifying those at high risk or low risk of SUDEP is ...
BOSTON — Preliminary results from a meta-analysis have shown that antiepileptic drugs (AEDs) approved for adults with primary generalized tonic-clonic (PGTC) seizures are also effective in children ...
-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with ...
November is Epilepsy Awareness Month. Many people may already be aware of the condition from its prevalence in medical dramas, but that portrayal is often exaggerated and does not fully encapsulate ...
Brain CT shows right temporal lobe epilepsy with hypometabolism. Seizures in the elderly often mimic other conditions, such as transient ischemic attack or dementia. Don't be fooled into a ...
Nearly 3.5 million Americans living with epilepsy could benefit from bystander knowledge of proper seizure response.
Lacosamide 100mg, 150mg, 200mg; ext-rel caps. The precise mechanism by which Motpoly XR exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies ...
Younger adults with difficult-to-treat epilepsy may have early signs of chronic traumatic encephalopathy in their brain tissue, but it appears to be uncommon, according to a small, preliminary study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback